CD4 and non-small cell lung carcinoma: Purified CD4+ T cells from a cohort of non-small-cell lung carcinoma (NSCLC) patients showed a Tfh signature associated with heightened CTL proliferation and adoptive transfer of Tfh cells in a murine tumor model augmented CTL function and inhibited tumor growth in vivo (47).